DISEASE/TRAIT
Chronic hepatitis B infection
Monocyte count
Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)
Rheumatoid arthritis
Post bronchodilator FEV1/FVC ratio
High light scatter reticulocyte percentage of red cells
Systolic blood pressure
Multiple myeloma (hyperdiploidy)
3-hydroxypropylmercapturic acid levels in smokers
HDL cholesterol levels
Left ventricle wall thickness
Crohn's disease
Reticulocyte fraction of red cells
Acylcarnitine levels
LDL cholesterol levels
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)
Bipolar disorder
Amyotrophic lateral sclerosis
Bipolar disorder and schizophrenia
Urate levels in overweight individuals
Ankylosing spondylitis
Hemoglobin concentration
Thyroid hormone levels
Waist-to-hip ratio adjusted for body mass index
Mean corpuscular hemoglobin
Height
Stem cell factor levels
Urinary albumin excretion rate in type 1 diabetes
Telomere length
Vitiligo
Diisocyanate-induced asthma
Myeloid white cell count
Hyperactive-impulsive symptoms
Interleukin-2 receptor antagonist levels
Waist-to-hip ratio adjusted for BMI in non-smokers
Height
Exploratory eye movement dysfunction in schizophrenia (number of eye fixations)
Blood pressure
HIV-1 control
Chronic bronchitis and chronic obstructive pulmonary disease
Attention deficit hyperactivity disorder (combined symptoms)
Autism spectrum disorder or schizophrenia
Breast cancer
White blood cell count
Cholesterol, total
QRS duration
Prudent dietary pattern
IgG glycosylation
Lung adenocarcinoma
Advanced age-related macular degeneration
Inflammatory bowel disease
Eosinophil percentage of granulocytes
Breast cancer
Body mass index
Platelet-derived growth factor BB levels
Pediatric bone mineral content (hip)
Urinary metabolites
Pelvic organ prolapse (moderate/severe)
Obesity-related traits
IgG glycosylation
Reticulocyte fraction of red cells
Obesity-related traits
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)
Cognitive ability
antipsychotic drug dosage in schizophrenia or schizoaffective disorder
Coronary artery disease
Metabolite levels (HVA/5-HIAA ratio)
Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)
Post bronchodilator FEV1/FVC ratio
Coronary artery disease
Rheumatoid arthritis
Post bronchodilator FEV1/FVC ratio
Total cholesterol levels
Inflammatory bowel disease
Cancer (pleiotropy)
Height
Diisocyanate-induced asthma
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
Response to haloperidol in psychosis
Response to antipsychotic treatment in schizophrenia (reasoning)
Obesity
Allergic disease (asthma, hay fever or eczema)
Type 2 diabetes
Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
Cerebrospinal P-tau181p levels
Protein quantitative trait loci
Ulcerative colitis
Breast cancer
Eosinophil percentage of white cells
Monocyte count
Inflammatory bowel disease
Daytime sleep phenotypes
Cannabis dependence symptom count
Educational attainment
Multiple myeloma
Menopause (age at onset)
Post bronchodilator FEV1/FVC ratio
